TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI

Core Viewpoint - The article discusses the impact of AI on the stock market, highlighting both the panic surrounding AI's potential negative effects and the opportunities it presents for certain companies, particularly in the healthcare sector. Group 1: Market Sentiment and AI Impact - The stock market experienced a decline due to a speculative report from Citrini Research predicting a "Global Intelligence Crisis" that could lead to significant unemployment and economic downturns, particularly affecting transaction intermediaries like Visa and Mastercard [5][4] - Rev notes that while there are legitimate concerns about AI disrupting business models, the current market reaction reflects irrational panic rather than rational analysis [3][4] Group 2: Stock Picks Benefiting from AI - Rev identifies three healthcare companies that are expected to benefit from AI advancements: - Harrow (HROW) is focusing on operational efficiency by consolidating operations and expanding its salesforce, with a price target of $69 based on analyst forecasts [8] - Xeris Biopharma (XERS) is leveraging AI to accelerate clinical trials for its hypothyroidism treatment, with a market potential of $1 billion and a price target of $9.67 [9] - Vir Biotechnology (VIR) is using AI to expedite drug development, recently securing a deal worth $335 million plus potential milestones, with a price target of $20.14 [10] Group 3: Pet Care Market Insights - The pet care market is growing, with 90 million households owning pets and spending approximately $157 billion annually, of which $80 billion is on health and wellness [15][16] - IDEXX Laboratories (IDXX) derives 90% of its revenue from veterinary diagnostics and is expected to grow earnings at 25% annually, with a bullish price target of $778.57 from analysts [16][17]